Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
University of Nova Gorica
University
Study
Research
Repository of University of Nova Gorica
About
Search
Browse
Statistics
Login
Show document
A+
|
A-
|
|
SLO
|
ENG
Title:
Izboljšanje procesa proizvodnje z metodo six sigma
Authors:
ID
Ipavec, Marko
(Author)
ID
Manzin, Massimo
(Mentor)
More about this mentor...
Files:
http://www.ung.si/~library/diplome/PTF/182Ipavec.pdf
182Ipavec.pdf
(1,41 MB)
MD5: 1162FBF13EFA53DF481B0D420583AF57
Language:
Slovenian
Work type:
Undergraduate thesis
Typology:
2.11 - Undergraduate Thesis
Organization:
PTF - Faculty of Engineering and Management
Keywords:
diplomske naloge
,
poslovne strategije
,
six sigma
,
management
Place of publishing:
Nova Gorica
Publisher:
M. Ipavec
Year of publishing:
2011
Number of pages:
VIII, 48 str.
PID:
20.500.12556/RUNG-970
COBISS.SI-ID:
1781499
UDC:
005.21
NUK URN:
URN:SI:UNG:REP:FQJXGTKX
Publication date in RUNG:
15.10.2013
Views:
7514
Downloads:
538
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
IPAVEC, Marko, 2011,
Izboljšanje procesa proizvodnje z metodo six sigma
[online]. Bachelor’s thesis. Nova Gorica : M. Ipavec. [Accessed 9 April 2025]. Retrieved from: https://repozitorij.ung.si/IzpisGradiva.php?lang=eng&id=970
Copy citation
Average score:
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
(0 votes)
Your score:
Voting is allowed only for
logged in
users.
Share:
Similar works from our repository:
Influence of diet on gastrointestinal disease
Nursing care of child with chronic inflammatory bowel (Crohn's disease)
Similar works from other repositories:
Infliximab through as a biomarker for inflammatory bowel disease
The relationship of serum concentrations of vedolizumab and ustekinumab with treatment outcomes in inflammatory bowel disease
Secondary amyloidosis with inflammatory bowel disease and nephrotic syndrom
ǂThe ǂimportance of undetectable inflicamab t(h!)rough levels for clinical outcome of patients with inflammatory bowel disease
Recent advances in the etiology of the chronic inflammatory bowel disease
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.
Back